META HEALTH LIMITED v CHUA KHENG CHOON & 5 Ors

Q: Which legislation does [2026] SGHC 109 consider?

The judgment refers to Arbitration Act (Cap 10), Evidence Act (Cap 97), International Arbitration Act (Cap 143A), and Supreme Court of Judicature Act (Cap 322). The statutes cited are listed in full on this page, each linking to its primary text.

[2026] SGHC 109 High Court (General Division) 20 May 2026 • HC/OC 737/2025 ( HC/RA 47/2026 ) • 25 min read

5 cases cited (4 SG, 1 foreign)

Catchwords

Courts And Jurisdiction — Jurisdiction — Singapore International Commercial Court

Practice Areas

Courts And Jurisdiction

Judges (1)

Andre Maniam Delivered

Counsel (7)

FC Legal Asia LLC Firm Rajah & Tann Singapore LLP Firm Ashwin Kumar Menon Counsel Plaintiff Chua Hua Yi Counsel Defendant Foo Maw Shen Counsel Defendant Goh Jia Jie Counsel Defendant Vikram Nair Counsel Plaintiff

Parties (7)

Meta Health Limited Plaintiff Chua Kheng Choon Defendant Hong Shieh Yung Travis Defendant Kelvin Lee Ming Hui Defendant Koh Gim Hoe Defendant Leow Siew Yon Defendant Mak Peng Leong Philip Defendant

Case Significance

Meta Health Limited v Chua Kheng Choon and others [2026] SGHC 109 is a High Court General Division decision by Andre Maniam J on 20 May 2026 on the jurisdiction of the Singapore International Commercial Court. Meta Health, a Singapore Exchange-listed company, brought claims against six individual defendants relating to its acquisition of Gainhealth Pte Ltd between 2021 and 2022, which its current management believed may not have been legitimate. After discontinuing against the fourth defendant in January 2026, Meta Health successfully applied to transfer the case to the SICC, but defendant Leow Siew Yon appealed that transfer order (RA 47 of 2026). Rajah & Tann Singapore LLP acted for Meta Health and FC Legal Asia LLC for the defendants.

[2026] SGHC 109 explained

META HEALTH LIMITED v CHUA KHENG CHOON & 5 Ors ([2026] SGHC 109) is a Singapore judgment decided by the High Court (General Division) on 20 May 2026. It is categorised under Courts And Jurisdiction. It is a recent decision; within this corpus no later judgment has cited it yet. This page summarises what the reported decision covers and links the primary sources — the full judgment, the statutes it cites, and the other cases it engages with — so the decision can be read in context. It is reference information, not legal advice, and it does not state the outcome or any holding beyond what the official judgment records.

What is [2026] SGHC 109 about?

META HEALTH LIMITED v CHUA KHENG CHOON & 5 Ors ([2026] SGHC 109) is a High Court (General Division) decision from 2026. Its published catchwords are “Courts And Jurisdiction — Jurisdiction — Singapore International Commercial Court”, which indicate the subject matter the judgment addresses. The full reasoning and orders are in the judgment itself, linked below.

Which legislation does [2026] SGHC 109 consider?

The judgment refers to Arbitration Act (Cap 10), Evidence Act (Cap 97), International Arbitration Act (Cap 143A), and Supreme Court of Judicature Act (Cap 322). The statutes cited are listed in full on this page, each linking to its primary text.

Summary

Meta Health Limited, a listed Singapore company, sought to transfer its High Court claim against six former directors and associates — alleging a fraudulent scheme in the 2021–2022 acquisition of Gainhealth Pte Ltd to misappropriate the company's assets — to the Singapore International Commercial Court. The third defendant, Ms Leow, appealed against the assistant registrar's order allowing the transfer, arguing the SICC was not the appropriate forum given that all parties were Singaporean and key witnesses were local. The court allowed Ms Leow's appeal, set aside the transfer order, and found that the considerations relied upon by Meta Health to support SICC transfer did not justify the move.

What was the jurisdiction question in Meta Health Limited v Chua Kheng Choon [2026] SGHC 109?

Andre Maniam J decided on 20 May 2026 whether a transfer of Meta Health's claims — arising from its acquisition of Gainhealth Pte Ltd between 2021 and 2022 — to the Singapore International Commercial Court was proper, after defendant Leow Siew Yon appealed the registrar's order granting the transfer.